JP Morgan analyst Anthony Paolone downgrades Essex Property Trust (NYSE:ESS) from Overweight to Neutral and lowers the price target from $284 to $267.
Piper Sandler Maintains Overweight on OncoCyte, Raises Price Target to $1.5
Piper Sandler analyst David Westenberg maintains OncoCyte (NASDAQ:OCX) with a Overweight and raises the price target from $1.4 to $1.5.